1. Advances in the Biosciences;C. Gespach,1985
2. H. M. Howard, M. J. Collen, J. A. Cherner, K. A. McArthur, P. N. Maton and J. D. Gardner,Famotidine: an effecctive, potent H 2 antagonist for the therapy of Zollinger-Ellison syndrome, Gastroenterology86, 1117 (1984).
3. J. M. Howard, A. N. Chrenos, M. J. Collen, K. E. McArthur, J. A. Cherner, P. N. Maton, C. A. Ciarleglio, M. J. Cornelins, J. D. Gardner, and R. T. Jensen,Famotidine, a new potent, long-acting histamine H 2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome, Gastroenterology88, 1026–1033 (1985).
4. C. Gespach, S. Emami, N. Boige and G. Rosselin,Chemical differentiation of histamine receptors coupled to cyclic AMP generation in human and guinea pig fundic glands. InGut peptides and ulcer, pp. 55–63 (Ed. A. Miyoshi), Biomedical Research Foundation, Tokyo 1983.
5. S. Emami, C. Gespach, M.-E. Forgue-Lafitte, Y. Broer and G. Rosselin,Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cell line HGT-1, Life Sci.33, 415–423 (1983).